摘要 |
<p>In the present invention there is disclosed a pharmaceutical preparation suitable for treatment or protection of vertebrates against parasites, containing a physiologically acceptable carrier and a [((3,5-bis-trifluoromethyl)phenyl)sulfonyl, [(4-fluorophenyl)sulfonyl], [(2,4-di-chlorophenyl)sulfonyl], [(phenyl)sulfonyl], [((4-trifluoromethoxy)phenyl)sulfonyl], [(3,4-dichlorophenyl)sulfonyl], [((4-trifluoromethyl)phenyl)sulfonyl], [(2,4,5-trichlorophenyl)sulfonyl], [(3-chloro-4-fluorophenyl)sulfonyl], [(4-chloro-phenyl)sulfonyl], [((3-trifluoromethyl)phenyl)sulfonyl], [(pentachlorophenyl)sulfonyl], [(4-nitro-phenyl)sulfonyl] or [(3-nitro-4-chlorophenyl)sulfonyl] derivative of [(trifluoromethyl)sulfonyl]methane or a physiologically acceptable, particularly levamisole salt of any of the above specified derivatives. In the present invention there are also claimed novel disulfonyl methane derivatives.</p> |